Connectivity of diagnostic technologies: Improving surveillance and accelerating tuberculosis elimination

International Journal of Tuberculosis and Lung Disease

Volumn 20, Issue 8, 2016, Pages 999-1003

  Andre, E ^a,b,c   Isaacs, C ^d   Affolabi, D ^e,f   Alagna, R ^g   Brockmann, D ^h,i   De Jong, B C ^j   Cambau, E ^c,k,l   Churchyard, G ^m   Cohen, T ⁿ   Delmee, M ^a,b   Delvenne, J C ^a,o   Farhat, M ^p   Habib, A ^q   Holme, P ^r   Keshavjee, S ^s   Khan, A ^t   Lightfoot, P ^d   Moore, D ^u   Moreno, Y ^v   Mundade, Y ^w   Pai, M ^x   Patel, S ^y   Nyaruhirira, A U ^z   Rocha, L E C ^aa,ab   Takle, J ^ac   Trebucq A ^ad   Creswell, J ^ae   Boehme, C ^d   more..

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^c European Study Group for Biofilms (ESGB)   (Switzerland)

^d FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS   (Switzerland)

^e UNIVERSITY OF ABOMEY CALAVI   (Benin)

^f National Tuberculosis Programme   (Benin)

^g SAN RAFFAELE HOSPITAL   (Italy)

^h HUMBOLDT UNIVERSITY   (Germany)

ⁱ ROBERT KOCH INSTITUTE   (Germany)

^j INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^k UNIVERSITÉ PARIS DESCARTES   (France)

^l HÔPITAL LARIBOISIÈRE   (France)

^m AURUM INSTITUTE   (South Africa)

ⁿ YALE UNIVERSITY   (United States)

^o Institute of Information and Communication Technologies Electronics and Applied Mathematics   (Belgium)

^p MASSACHUSETTS GENERAL HOSPITAL   (United States)

^q Interactive Health Solutions   (Pakistan)

^r Sungkyunkwan University   (South Korea)

^s HARVARD MEDICAL SCHOOL   (United States)

^t Maternal and Child Health   (Pakistan)

^u LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^v UNIVERSITY OF ZARAGOZA   (Spain)

^w UNITAID   (Switzerland)

^x MCGILL UNIVERSITY   (Canada)

^y UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^z Management Sciences for Health   (South Africa)

^aa KAROLINSKA INSTITUTE   (Sweden)

^ab UNIVERSITY OF NAMUR   (Belgium)

^ac Global Connectivity LLC   (United States)

^ad INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^ae Stop TB Partnership   (Switzerland)

more..

Author keywords

Connectivity; Data; Laboratory; Surveillance; Tuberculosis

Indexed keywords

HUMAN; LABORATORY TEST; MEDICAL INFORMATICS; MEDICAL TECHNOLOGY; PRIORITY JOURNAL; PUBLIC HEALTH; RAPID TEST; REVIEW; TUBERCULOSIS; TUBERCULOSIS CONTROL; ACCESS TO INFORMATION; DIAGNOSTIC KIT; DIAGNOSTIC TEST; ELECTRONIC HEALTH RECORD; EPIDEMIC; FORECASTING; INFORMATION RETRIEVAL; MEDICAL RECORD; MOLECULAR DIAGNOSIS; PREDICTIVE VALUE; PROGNOSIS; TIME FACTOR; TRANSMISSION; TRENDS;

ACCESS TO INFORMATION; DIAGNOSTIC TESTS, ROUTINE; ELECTRONIC HEALTH RECORDS; EPIDEMICS; FORECASTING; HUMANS; INFORMATION STORAGE AND RETRIEVAL; MEDICAL RECORD LINKAGE; MOLECULAR DIAGNOSTIC TECHNIQUES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REAGENT KITS, DIAGNOSTIC; TIME FACTORS; TUBERCULOSIS;

EID: 84978287640     PISSN: 10273719     EISSN: 18157920     Source Type: Journal    
DOI: 10.5588/ijtld.16.0015     Document Type: Review

References (16)

1. Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. NEngl JMed 2010; 363: 1005-1015.
2. Scott LE, Campbell J, Westerman L, et al. Ameta-analysis of the performance of the Pima CD4 for point of care testing. BMC Med 2015; 13: 168.
3. Creswell J, Codlin AJ, Andre E, et al. Results from early programmatic implementation of Xpertw MTB/RIF testing in nine countries. BMC Infect Dis 2014; 14: 2.
4. Raizada N, Sachdeva KS, Sreenivas A, et al. Feasibility of decentralised deployment of Xpertw MTB/RIF test at lower level of health system in India. PLOS ONE 2014; 9: E89301.
5. Theron G, Zijenah L, Chanda D, et al. Feasibility, accuracy, and clinical effect of point-of-care Xpertw MTB/RIF testing for tuberculosis in primary-care settings in Africa: A multicentre, randomised, controlled trial. Lancet 2014; 383: 424-435.
6. Ohno-Machado L. To share or not to share: That is not the question. Sci Transl Med 2012; 4: 165cm15.
7. Shinnick TM, Starks AM, Alexander HL, Castro KG. Evaluation of the Cepheid Xpertw MTB/RIF assay. Expert Rev Mol Diagn 2015; 15: 9-22.
8. Theron G, Jenkins HE, Cobelens F, et al. Data for action: Collection and use of local data to end tuberculosis. Lancet 2015; 386: 2324-2333.
9. Meyer-Rath G, Schnippel K, Long L, et al. The impact and cost of scaling up GeneXpert MTB/RIF in South Africa. PLOS ONE 2012; 7: E36966.
10. Uplekar M, Weil D, Lönnroth K, et al. WHO's new End TB strategy. Lancet 2015; 385: 1799-1801.
11. Wood E, Kerr T, Marshall BD, et al. Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: Prospective cohort study. BMJ 2009; 338: B1649.
12. Pai M, Schito M. Tuberculosis diagnostics in 2015: Landscape, priorities, needs, and prospects. JInfect Dis 2015; 211 (Suppl 2): S21-S28.
13. Starks AM, Aviles E, Cirillo DM, et al. Collaborative effort for a centralized worldwide tuberculosis relational sequencing data platform. Clin Infect Dis 2015; 61 (Suppl 3): S141-S146.
14. Fraser HS, Habib A, Goodrich M, et al. E-health systems for management of MDR-TB in resource-poor environments: A decade of experience and recommendations for future work. Stud Health Technol Inform 2013; 192: 627-631.
15. Lönnroth K, Migliori GB, Abubakar I, et al. Towards tuberculosis elimination: An action framework for lowincidence countries. Eur Respir J2015; 45: 928-952.
16. Stop TB Partnership. Global Plan to End TB: The paradigm shift 2016-2020. Geneva, Switzerland: United Nations Office for Project Services, 2016.